Conversation

Notices

1. Embed this notice
   Eric Topol (erictopol@mstdn.social)'s status on Thursday, 04-Apr-2024 07:54:54 JST Eric Topol

   Paxlovid didn’t provide any benefit in a placebo-controlled randomized trial in lower risk (mean age 42 years) outpatients with mild-to-moderate Covid

   https://www.nejm.org/doi/full/10.1056/NEJMoa2309003

   • Embed this notice
     Rote Blume (roteblume@mastodon.social)'s status on Thursday, 04-Apr-2024 07:54:58 JST Rote Blume

     in reply to

     • Sergio

     @sergiodomeyko @erictopol it's effective for high-risk patients for a severe systemic infection

   • Embed this notice
     Sergio (sergiodomeyko@mastodon.online)'s status on Thursday, 04-Apr-2024 07:54:59 JST Sergio

     in reply to

     @erictopol and wow o wow are they pushing commercials of this product on paramount +

     HistoPol (#HP) 🥥 🌴 repeated this.